CRIS Current Research Information System

CESCON, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.924
AS - Asia 16.734
EU - Europa 14.338
AF - Africa 1.310
SA - Sud America 1.129
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 9
Totale 54.489
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.715
SG - Singapore 5.379
CN - Cina 4.349
VN - Vietnam 3.475
GB - Regno Unito 3.000
IT - Italia 2.496
DE - Germania 2.242
SE - Svezia 1.640
HK - Hong Kong 1.357
NL - Olanda 1.095
IN - India 1.065
BR - Brasile 817
RU - Federazione Russa 728
FR - Francia 605
UA - Ucraina 568
IE - Irlanda 555
KR - Corea 384
CI - Costa d'Avorio 383
FI - Finlandia 295
ZA - Sudafrica 289
TG - Togo 273
EE - Estonia 215
CH - Svizzera 213
SC - Seychelles 186
JP - Giappone 168
BG - Bulgaria 158
AR - Argentina 143
CA - Canada 126
JO - Giordania 119
NG - Nigeria 110
ID - Indonesia 107
AT - Austria 105
BE - Belgio 85
PL - Polonia 76
EC - Ecuador 73
ES - Italia 66
MX - Messico 56
BD - Bangladesh 44
TR - Turchia 44
IR - Iran 40
AU - Australia 38
RO - Romania 37
PK - Pakistan 34
HR - Croazia 25
GR - Grecia 23
LT - Lituania 22
MK - Macedonia 22
IQ - Iraq 21
UZ - Uzbekistan 21
PE - Perù 20
PY - Paraguay 20
PH - Filippine 19
CO - Colombia 17
SA - Arabia Saudita 14
CL - Cile 13
MY - Malesia 13
CZ - Repubblica Ceca 12
MA - Marocco 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
DO - Repubblica Dominicana 9
KE - Kenya 9
LB - Libano 9
UY - Uruguay 9
PT - Portogallo 8
TN - Tunisia 7
DK - Danimarca 6
IL - Israele 6
LK - Sri Lanka 6
AL - Albania 5
AM - Armenia 5
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
ET - Etiopia 4
LU - Lussemburgo 4
PA - Panama 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CG - Congo 3
EU - Europa 3
GA - Gabon 3
KG - Kirghizistan 3
KH - Cambogia 3
SI - Slovenia 3
SN - Senegal 3
BO - Bolivia 2
BY - Bielorussia 2
GH - Ghana 2
GN - Guinea 2
HU - Ungheria 2
Totale 54.442
Salva come PNG Salva come JPEG
Città #
Singapore 3.559
Southend 2.595
Fairfield 2.419
Ashburn 2.318
Chandler 1.715
Hong Kong 1.350
Woodbridge 1.144
Dong Ket 1.094
Wilmington 954
Houston 937
Seattle 929
Hefei 878
Santa Clara 835
Cambridge 781
Princeton 737
Kerkrade 651
Ho Chi Minh City 628
Ann Arbor 623
Bologna 580
Beijing 559
Dublin 555
Boardman 509
Hanoi 448
Frankfurt am Main 440
Dallas 425
Abidjan 382
Seoul 377
Los Angeles 332
Jacksonville 325
Lomé 273
Westminster 270
Nanjing 263
Munich 245
Padova 229
Berlin 227
Helsinki 217
New York 210
Milan 186
Bern 185
Buffalo 161
Tokyo 157
Sofia 155
Redondo Beach 138
Jinan 137
Saint Petersburg 134
San Diego 125
Shenyang 124
Amman 119
Florence 117
Redmond 107
São Paulo 99
Delhi 96
Guangzhou 96
Dearborn 93
Turin 93
Rome 90
Nanchang 88
Hebei 87
Abeokuta 86
Changsha 84
Brussels 81
Medford 79
Des Moines 78
Bengaluru 75
Bremen 73
Chicago 70
Phoenix 65
Zhengzhou 65
Da Nang 63
Mülheim 62
London 60
Shanghai 60
Tianjin 60
Vienna 60
Falls Church 59
Haiphong 59
Jakarta 58
Falkenstein 57
Olalla 56
Hyderabad 53
Toronto 50
Jiaxing 49
Nuremberg 49
Norwalk 48
Turku 46
Düsseldorf 45
Amsterdam 44
Redwood City 44
Biên Hòa 40
Haikou 40
Hải Dương 40
Brooklyn 39
Warsaw 39
Hangzhou 38
Ningbo 37
Yubileyny 36
San Francisco 35
Mahé 34
The Dalles 34
Tongling 33
Totale 35.883
Salva come PNG Salva come JPEG
Nome #
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.215
The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study 612
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 464
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 315
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 290
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 286
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 285
A comprehensive analysis on expected years of life lost due to pancreatic cancer 278
Extracorporeal interval support for organ retrieval delivery regional experience with sharing equipe, equipment & expertise to increase conventionally defined as controlled donor pool in time of pandemic 272
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 272
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 265
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 244
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 243
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 240
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 237
A new liver transplant priority for patients with hepatocellular carcinoma. 236
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 229
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 228
Burnout and psychological distress between surgical and non-surgical residents 225
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 223
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 221
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 221
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 220
Surgical therapy for hepatolithiasis: a Western experience. 216
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 214
Use of perfusional angiosonography in liver transplantation and conservative management of post-transplant intra-hepatic pseudo-aneurysm. 207
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 202
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 199
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 199
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 199
Machine Learning Pipeline for the Automated Prediction of MicrovascularInvasion in HepatocellularCarcinomas 198
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 198
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 196
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 196
Bacterial translocation in adult small bowel transplantation 196
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 196
The peculiar aging of human liver: A geroscience perspective within transplant context 196
Combined liver–dual kidney transplant: Role in expanded donors 195
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 193
Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver 193
LncRNAs as novel players in hepatocellular carcinoma recurrence 193
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study 192
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 192
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 191
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 191
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 191
Coping strategies in intestinal transplantation 190
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 190
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 190
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 190
Acute cellular rejection monitoring after interstinal transplant: utility of serologic markers and zoom videoendoscopy as support of conventional biopsy and clinical findings. 189
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 188
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 187
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 187
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 185
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 185
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 185
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 184
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 183
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 182
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 181
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 180
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 179
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 179
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 179
Efficacy of MELD score in predicting survival after liver retransplantation. 178
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 177
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 175
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 175
Using Elderly Donors in Liver Transplantation. 174
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 174
Combined heart-liver transplantation: A single-center experience 173
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 173
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 172
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 171
In Reply 171
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 171
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 171
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 171
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 170
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 170
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 170
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 170
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 170
Automatically extracted machine learning features from preoperative CT to early predict microvascular invasion in HCC: the role of the Zone of Transition (ZOT) 170
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 168
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies 165
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 165
Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients. 165
Split-liver transplantation with pediatric donors: a multicenter experience. 164
null 164
Impact of preoperative infection on outcome after liver transplantation 164
Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications 164
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. 163
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 163
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network 163
Age and equity in liver transplantation: An organ allocation model. 162
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 161
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 160
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 160
Totale 21.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.447 0 0 0 0 0 230 108 265 439 324 217 1.864
2021/20226.542 496 236 357 521 587 282 163 505 298 405 1.602 1.090
2022/20237.563 722 1.101 385 970 504 612 235 490 1.346 205 575 418
2023/20242.300 196 405 150 218 178 384 108 146 89 175 133 118
2024/20259.962 483 1.363 850 762 1.363 543 717 341 226 792 580 1.942
2025/202613.649 2.155 2.636 2.247 1.746 2.496 2.369 0 0 0 0 0 0
Totale 55.611